Cannabis LP Stocks Were +6% Last Week Vs. -10% The Previous Week
Image Source: Unsplash
Introduction
The Canadian Cannabis LP Stocks Portfolio bounced back from a 10% decline the previous week (w/e Sept. 6th) as the negative sentiment waned surrounding the DEA's announcement that it would be having a December 2nd hearing to consider additional opinions on the Justice Department’s proposal that cannabis be re-classified to that of a Schedule III drug under the Controlled Substances Act,
Our Canadian Cannabis LP Portfolio
Here’s what happened last week, in descending order, for the 5 largest Canadian Licensed Producers and for the previous 2 weeks:
- Tilray Brands (TLRY):
- UP 7.4% w/e Sept. 13th
- DOWN 5.3% w/e Sept. 6th
- DOWN 11.4% w/e August 30th
- Aurora Cannabis (ACB):
- UP 7.0% w/e Sept. 13th
- DOWN 11.0% w/e Sept. 6th
- DOWN 6.6% w/e August 30th
- Canopy Growth (CGC):
- UP 6.9% w/e Sept. 13th
- DOWN 14.0% w/e Sept. 6th
- DOWN 16.1% w/e August 30th
- Organigram (OGI):
- UP 6.9% w/e Sept. 13th
- DOWN 5.4% w/e Sept. 6th
- DOWN 8.4% w/e August 30th
- Cronos Group (CRON):
- UP 2.3% w/e Sept. 13th
- DOWN 5.7% w/e Sept. 6th
- DOWN 3.0% w/e August 30th
Summary
The Canadian Cannabis LP Stocks Portfolio went UP 6.4% last week vs. going DOWN 10.0% w/e Sept. 6th and DOWN 9.1% w/e August 30th. The Portfolio is now UP 4.1% YTD.
More By This Author:
Our Quantum Computing Portfolio Was -9.8% Week-Ending September 6th
Our Computer Chips-Related Portfolio Was -12% Week-Ending Sept. 6th
Our Small Cap AI Portfolio Was -10% Week-Ending Sept. 6th
Disclosure: None
This article has been composed with the exclusive application of the human intelligence (HI) of the author. No artificial intelligence (AI) technology has been deployed.
Lorimer, Why have you started writing articles that say absolutely nothing of substenance? You used to have good content, but now it's all just fluff and filler.